Stocksigma LogoStocksigma Logo

Emcure Pharmaceuticals Reports Strong Q2FY27 Results Led by International Growth

Emcure Pharmaceuticals reported Q2FY27 revenue from operations of INR 28,205 Mn, up 24.3% YoY and 9.3% QoQ, driven by a 34.5% YoY rise in international

Emcure Pharmaceuticals Reports Strong Q2FY27 Results Led by International Growth

Emcure Pharmaceuticals Ltd 路 Investor Presentation 路 03 Nov 2026, 7:34 pm

Emcure Pharmaceuticals Reports Strong Q2FY27 Results Led by International Growth Emcure Pharmaceuticals reported Q2FY27 revenue from operations of INR 28,205 Mn, up 24.3% YoY and 9.3% QoQ, driven by a 34.5% YoY rise in international sales and 12.0% YoY growth in domestic business. EBITDA rose 30.9% YoY to INR 5,748 Mn, with margins expanding 103 bps to 20.4%. PAT increased 29.3% YoY to INR 3,251 Mn with an 11.5% margin. As of 30th Sep'26, RoCE expanded to 24.9%, while net debt stood at INR 13,171 Mn due to Mantra earnouts and Gennova consolidation payments.

Original exchange filing (PDF)

More announcements from Emcure Pharmaceuticals Ltd

All Emcure Pharmaceuticals Ltd announcements